Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $840.40 | 9 | 57.8% |
| Education | $612.87 | 7 | 42.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $434.88 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $315.23 | 3 | $0 (2023) |
| BeiGene USA, Inc. | $233.71 | 2 | $0 (2022) |
| ADC Therapeutics America, Inc. | $151.40 | 3 | $0 (2023) |
| Exelixis Inc. | $124.07 | 1 | $0 (2023) |
| Genmab U.S., Inc. | $110.99 | 1 | $0 (2023) |
| ABBVIE INC. | $82.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $594.21 | 6 | AstraZeneca Pharmaceuticals LP ($220.23) |
| 2022 | $459.27 | 6 | Astellas Pharma US Inc ($159.94) |
| 2021 | $399.79 | 4 | Astellas Pharma US Inc ($274.94) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $110.99 | General |
| Category: Oncology | ||||||
| 05/18/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Education | In-kind items and services | $82.99 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $95.36 | General |
| Category: Oncology | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: Respiratory | ||||||
| 05/03/2023 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $124.07 | General |
| Category: Oncology | ||||||
| 01/08/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $55.93 | General |
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Education | In-kind items and services | $95.00 | General |
| Category: Oncology | ||||||
| 10/07/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.77 | General |
| 10/07/2022 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $46.70 | General |
| 08/01/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 08/01/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $59.99 | General |
| 04/20/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $108.86 | General |
| Category: Oncology | ||||||
| 11/11/2021 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: Oncology | ||||||
| 10/04/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 10/04/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.99 | General |
| 03/03/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 18 | $4,050 | $1,940 |
| 2020 | 3 | 86 | 158 | $79,302 | $14,304 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 18 | $4,050 | $1,940 | 47.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 50 | 120 | $53,640 | $9,673 | 18.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 21 | $14,952 | $3,239 | 21.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 16 | 17 | $10,710 | $1,392 | 13.0% |
About Chad Glisch
Chad Glisch is a Internal Medicine healthcare provider based in West Allis, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1134514078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chad Glisch has received a total of $1,453 in payments from pharmaceutical and medical device companies, with $594.21 received in 2023. These payments were reported across 16 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($840.40).
As a Medicare-enrolled provider, Glisch has provided services to 100 Medicare beneficiaries, totaling 176 services with total Medicare billing of $16,244. Data is available for 2 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location West Allis, WI
- Active Since 03/30/2015
- Last Updated 10/20/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134514078
Products in Payments
- BRUKINSA (Drug) $233.71
- BREZTRI (Drug) $124.87
- CABOMETYX (Drug) $124.07
- Epkinly (Drug) $110.99
- CALQUENCE (Drug) $95.36
- FASLODEX (Drug) $95.00
- VENCLEXTA (Drug) $82.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Allis
Nishant Vaidy, Md, MD
Internal Medicine — Payments: $3,562
Masroor Munim, Md, MD
Internal Medicine — Payments: $2,001
Laurence Donahue, M.d, M.D
Internal Medicine — Payments: $1,767
Maqsood Khan, M.d, M.D
Internal Medicine — Payments: $719.09
Malini Mehta, M.d, M.D
Internal Medicine — Payments: $458.35
Hashim Sadig, M.d, M.D
Internal Medicine — Payments: $381.25